Identification of the binding site of 55kDa tumor necrosis factor receptor by synthetic peptides. 1992

B L Lie, and D Tunemoto, and H Hemmi, and Y Mizukami, and H Fukuda, and H Kikuchi, and S Kato, and N Numao
Sagami Chemical Research Center, Kanagawa, Japan.

We have synthesized a series of peptides, which cover almost the whole range of the N-terminal extracellular domain of human 55kDa TNF receptor (55kDa TNF-R). The peptides were examined for the binding activity to TNF by solid phase binding assay and for the inhibition of TNF cytotoxicity to mouse L-M cells. The peptide 159-178 exhibited remarkably higher binding activity to TNF than other peptides did. The specificity of the TNF binding to the peptides was confirmed by their inability to bind other cytokines. The peptide 159-178 also inhibited TNF cytotoxicity. These results indicate that the specific binding site of 55kDa TNF-R to TNF might reside within the peptide segment of amino acid numbers 159 to 178 in the N-terminal extracellular domain.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

B L Lie, and D Tunemoto, and H Hemmi, and Y Mizukami, and H Fukuda, and H Kikuchi, and S Kato, and N Numao
April 2004, Current opinion in structural biology,
B L Lie, and D Tunemoto, and H Hemmi, and Y Mizukami, and H Fukuda, and H Kikuchi, and S Kato, and N Numao
January 2024, Veterinary sciences,
B L Lie, and D Tunemoto, and H Hemmi, and Y Mizukami, and H Fukuda, and H Kikuchi, and S Kato, and N Numao
December 1994, The Journal of infectious diseases,
B L Lie, and D Tunemoto, and H Hemmi, and Y Mizukami, and H Fukuda, and H Kikuchi, and S Kato, and N Numao
July 2002, Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA,
B L Lie, and D Tunemoto, and H Hemmi, and Y Mizukami, and H Fukuda, and H Kikuchi, and S Kato, and N Numao
November 1992, The Journal of biological chemistry,
B L Lie, and D Tunemoto, and H Hemmi, and Y Mizukami, and H Fukuda, and H Kikuchi, and S Kato, and N Numao
November 2003, The Journal of biological chemistry,
B L Lie, and D Tunemoto, and H Hemmi, and Y Mizukami, and H Fukuda, and H Kikuchi, and S Kato, and N Numao
July 1992, Archives of biochemistry and biophysics,
B L Lie, and D Tunemoto, and H Hemmi, and Y Mizukami, and H Fukuda, and H Kikuchi, and S Kato, and N Numao
May 2007, The journal of investigative dermatology. Symposium proceedings,
B L Lie, and D Tunemoto, and H Hemmi, and Y Mizukami, and H Fukuda, and H Kikuchi, and S Kato, and N Numao
March 1987, Journal of leukocyte biology,
B L Lie, and D Tunemoto, and H Hemmi, and Y Mizukami, and H Fukuda, and H Kikuchi, and S Kato, and N Numao
June 1999, The Journal of experimental medicine,
Copied contents to your clipboard!